ArticleNanoscale2026
Flash nanoprecipitation of magnetic particle imaging tracers with tunable performance.
Article in Nanoscale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Magnetic particle imaging (MPI) is a novel biomedical imaging modality where biocompatible magnetic nanoparticle (MNP) tracers produce a quantitative signal for imaging applications like pharmacokinetics studies, blood pooling, cell tracking, and more. Improvements to tracer performance are generally made through the alteration of the synthesis mechanism and post-synthesis surface modification tailored to different applications. However, relying on synthesis alone to modify MPI performance can be difficult and time consuming. This study utilized flash nanoprecipitation, a method of MNP encapsulation, to vary the MPI performance of tracers. Herein, composite nanoparticle tracers were produced by precipitating hydrophobic iron oxide nanoparticles and homopolymer in water and stabilizing them with an amphiphilic block copolymer. By increasing the concentration of homopolymer used in precipitation, composite nanoparticle tracers with a range of physical properties and MPI performances were obtained, until a peak MPI performance was achieved and after which additional homopolymer did not further improve performance. Two pre-clinical applications of this work were demonstrated; the first was an
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.